Hawkeye Systems (HWKE) 10-Q8 Feb 242024 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Dec. 31, 2023	Feb. 08, 2024
Cover [Abstract]
Entity Registrant Name	HAWKEYE SYSTEMS, INC.
Entity Central Index Key	0001750777
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		5,552,222
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-180954
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	83-0799093
Entity Address Address Line 1	6605 Abercorn
Entity Address Address Line 2	Suite 204
Entity Address City Or Town	Savannah
Entity Address State Or Province	GA
Entity Address Postal Zip Code	31405
City Area Code	912
Local Phone Number	253-0375
Entity Interactive Data Current	Yes

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current assets:
Cash	$ 398	$ 143,861
Prepaid expenses	10,000	2,370
Interest receivable	116,893	40,438
Loan receivable	1,548,000	800,000
Total current assets	1,675,291	986,669
Total assets	1,675,291	986,669
Current liabilities:
Accounts payable and accrued liabilities - related party	383,718	730,454
Accounts payable and accrued liabilities	15,580	13,644
Convertible note payable, net of discount - related party	500,000	500,000
Accrued interest - related party	491,802	298,158
Line of credit - related party	525,000	525,000
Promissory note payable - related party	1,729,750	1,000,000
Total current liabilities	3,645,850	3,067,256
Long-term liabilities:
Loan payable due to Eagle - JV partner	442,251	442,251
Total liabilities	4,088,101	3,509,507
Commitments and contingencies (Note -13)	0	0
Stockholders' deficit:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 5,552,222 and 5,552,222 shares issued and outstanding, respectively	555	555
Common shares to be Issued	497,528	0
Additional paid-in capital	9,585,094	9,585,094
Accumulated deficit	(12,495,987)	(12,108,487)
Total stockholders' deficit	(2,412,810)	(2,522,838)
Total liabilities and stockholders' deficit	$ 1,675,291	$ 986,669

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2023	Jun. 30, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	5,552,222	5,552,222
Common stock, shares outstanding	5,552,222	5,552,222

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
General and administrative	$ 16,170	$ 21,212	$ 37,765	$ 48,966
Management compensation	78,167	111,250	189,417	222,551
Professional fees	37,133	86,865	73,129	107,291
Professional fees - related party	0	0	0	15,000
Total operating expenses	131,470	219,327	300,311	393,808
Loss from operations	(131,470)	(219,327)	(300,311)	(393,808)
Other income (expense), net:
Other income	15,000	0	30,000	0
Interest income	44,450	0	76,454	0
Interest expense - related party	(101,234)	(46,965)	(193,644)	(87,580)
Total other income (expense), net	(41,784)	(46,965)	(87,190)	(87,580)
Net loss before income taxes provision	(173,254)	(266,292)	(387,501)	(481,388)
Provision for income tax	0	0	0	0
Net loss	$ (173,254)	$ (266,292)	$ (387,501)	$ (481,388)
Net loss per common share - basic and diluted	$ (0.03)	$ (0.10)	$ (0.07)	$ (0.10)
Weighted average common shares outstanding - basic and diluted	5,552,222	4,227,082	5,552,222	3,982,582

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock to be issued	Retained Earnings (Accumulated Deficit)
Balance, shares at Jun. 30, 2022		2,560,416
Balance, amount at Jun. 30, 2022	$ (2,103,529)	$ 256	$ 8,778,391		$ (10,882,176)
Common stock issued for common stock payable, shares		1,666,667
Common stock issued for common stock payable, amount	594,344	$ 167	594,177		0
Stock based compensation - options	5,159	$ 0	5,159		0
Net loss	(215,096)				(215,096)
Balance, shares at Sep. 30, 2022		4,227,083
Balance, Amount at Sep. 30, 2022	(1,719,122)	$ 423	9,377,727		(11,097,272)
Balance, shares at Jun. 30, 2022		2,560,416
Balance, amount at Jun. 30, 2022	(2,103,529)	$ 256	8,778,391		(10,882,176)
Stock based compensation - options	5,159
Net loss	(481,388)
Balance, shares at Dec. 31, 2022		4,227,083
Balance, Amount at Dec. 31, 2022	(1,985,414)	$ 423	9,377,727		(11,363,564)
Balance, shares at Sep. 30, 2022		4,227,083
Balance, amount at Sep. 30, 2022	(1,719,122)	$ 423	9,377,727		(11,097,272)
Net loss	(266,292)	$ 0	0		(266,292)
Balance, shares at Dec. 31, 2022		4,227,083
Balance, Amount at Dec. 31, 2022	(1,985,414)	$ 423	9,377,727		(11,363,564)
Balance, shares at Jun. 30, 2023		5,552,223
Balance, amount at Jun. 30, 2023	(2,522,838)	$ 555	9,585,094	$ 0	(12,108,487)
Net loss	(214,247)			0	(214,247)
Balance, shares at Sep. 30, 2023		5,552,223
Balance, Amount at Sep. 30, 2023	(2,737,085)	$ 555	9,585,094	0	(12,322,734)
Balance, shares at Jun. 30, 2023		5,552,223
Balance, amount at Jun. 30, 2023	(2,522,838)	$ 555	9,585,094	0	(12,108,487)
Stock based compensation - options	0
Net loss	(387,501)
Balance, shares at Dec. 31, 2023		5,552,223
Balance, Amount at Dec. 31, 2023	(2,412,810)	$ 555	9,585,094	497,528	(12,495,987)
Balance, shares at Sep. 30, 2023		5,552,223
Balance, amount at Sep. 30, 2023	(2,737,085)	$ 555	9,585,094	0	(12,322,734)
Stock based compensation - options	497,528	0	0	497,528	0
Net loss	(173,254)	$ 0	0	0	(173,254)
Balance, shares at Dec. 31, 2023		5,552,223
Balance, Amount at Dec. 31, 2023	$ (2,412,810)	$ 555	$ 9,585,094	$ 497,528	$ (12,495,987)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (387,501)	$ (481,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation - options and warrant	0	5,159
Common stock issued for settlement of compensation	497,528	0
Change in operating assets and liabilities:
Prepaid expense	(7,631)	(8,147)
Interest receivable	(76,455)	0
Accounts payable and accrued liabilities- related party	(346,735)	284,083
Accounts payable and accrued liabilities	1,936	0
Accrued interest - related party	193,644	0
Net cash used in operating activities	(125,213)	(200,293)
Cash flows from investing activities:
Note receivable from CNTNR	(748,000)	0
Net cash used in investing activities	(748,000)	0
Cash flows from financing activities:
Net proceeds from Promissory note - related party	729,750	0
Net proceeds from line of credit	0	200,000
Net cash provided by financing activities	729,750	200,000
Net change in cash	(143,463)	(293)
Cash beginning of period	143,861	325
Cash end of period	398	32
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Common stock issued exchanged for common stock payable - related party	0	594,344
Common stock to be issued for settlement of service	$ 497,528	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2023
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 1 - Summary of Significant Accounting Policies Business Overview Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources. Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”). Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023. Use of estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets. Fair value measurements When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis. Revenue recognition As of December 31, 2023, and 2022, the Company had no revenue. Cost of sales As of December 31, 2023, and 2022, the Company had no cost of sales. Basic and diluted earnings per share Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended December 31, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows: December 31, December 31, 2023 2022 Warrants 239,401 239,401 Options 425,600 425,600 Convertible notes 6,972,559 5,679,287 Total possible dilutive shares 7,637,560 6,344,288 Recent accounting pronouncements Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

Going Concern

Going Concern	6 Months Ended
Going Concern	Dec. 31, 2023
Going Concern
Going Concern	Note 2 - Going Concern The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the six months ended December 31, 2023, the Company had a net loss of $387,501, and had an accumulated deficit of $12,495,987 as of December 31, 2023. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern. In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company include: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan. There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Loan payable due to Eagle JV pa

Loan payable due to Eagle JV partner	6 Months Ended
Loan payable due to Eagle JV partner	Dec. 31, 2023
Loan payable due to Eagle JV partner
Loan payable due to Eagle - JV partner	Note 3 – Loan payable due to Eagle - JV partner July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Membership Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the Membership Agreement. HIE did not have any operating activities since July 2021. As a result, the Company’s investment balance in HIE as of December 31, 2023 was $0, and the loan balance payable to joint venture partner Eagle totaled $442,251, unchanged since year 2021.

Related Party Transactions

Related Party Transactions	6 Months Ended
Related Party Transactions	Dec. 31, 2023
Related Party Transactions
Related Party Transactions	Note 4 - Related Party Transactions Related party transactions are described in detail in Note 5, Note 6, Note 7, Note 8, and Note 10.

Inventory Financing Payable rel

Inventory Financing Payable related party	6 Months Ended
Inventory Financing Payable related party	Dec. 31, 2023
Inventory Financing Payable related party
Inventory Financing Payable - related party	Note 5 – Inventory Financing Payable – related party On February 19, 2021, Steve Hall, a shareholder of the Company, advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle. In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall agreed to allow the Company to retain the balance to fund future purchases and general operating expenses. On October 1, 2021, the Company and Steve Hall entered into a restated and amended promissory note, to consolidate and restate the terms pursuant to which Steve Hall had provided funds to the Company (the “Consolidated Note”). The Consolidated Note consolidated and restated the terms of advances made on February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter. Principal and interest due under the line of credit extended pursuant to the Consolidated Note shall be added to the principal amount due under the Consolidated Note and shall be payable pursuant to the same terms. The line of credit is due and payable on the Due Date unless extended. At the option of holder, the Consolidated Note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share. The Consolidated Note’s Due Date was extended to September 30, 2023 and, as of the date of this report, we have not received any notice from Steve Hall indicating his intention to collect or convert the principal and interest under the Consolidated Note. As of December 31, 2023, and 2022, the accrued interest under the Consolidated Note was $215,342, and $115,342, and the principal balance was $500,000 at the end of both years, respectively.

Line of Credit related party

Line of Credit related party	6 Months Ended
Line of Credit related party	Dec. 31, 2023
Line of Credit related party
Line of Credit - related party	Note 6 – Line of Credit – related party On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. All principal disbursed under the line of credit will accrue interest, and be payable on the same terms as principal due under the Consolidated Note (see Note 6). The line of credit expired on October 1, 2022. Subsequently, the line of credit has been orally renewed and extended with same terms and a new maturity date of October 1, 2023. Currently, the Company is working with Steve on extension on the Line of Credit. As of December 31, 2023, and 2022, the outstanding principal of the line of credit totaled $525,000, and $465,000, with accrued interest balances of $154,170, and $51,849, respectively.

Promissory notes payable relate

Promissory notes payable related party	6 Months Ended
Promissory notes payable related party	Dec. 31, 2023
Promissory notes payable related party
Promissory notes payable - related party	Note 7 – Promissory Notes Payable – related party On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make a follow-on investment in CNTNR USA, Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 9 - Note Receivable. As of December 31, 2023, the outstanding loan balance was $1,729,750 with accrued interest of $122,291. The Steve Hall Note is past its maturity date. The Company is currently working with Mr. Hall to restructure the note and extend its maturity date.

Accrued expenses related party

Accrued expenses related party	6 Months Ended
Accrued expenses related party	Dec. 31, 2023
Accrued expenses related party
Accrued expenses - related party	Note 8 – Accrued Expenses – related party Between September 2021 to September 2022, the Company had accepted deposits in the total amount of $33,218 from Central National Gottesman, Inc., on a sale of face masks on behalf of Steve Hall, a shareholder of Hawkeye Systems, Inc. As of December 31, 2023, the deposits remain with the Company and have not been sent to Mr. Hall. In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability.

Note receivable

Note receivable	6 Months Ended
Note receivable	Dec. 31, 2023
Note receivable
Note receivable	Note 9 – Note Receivable On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”). In the Amended CNTNR Note, the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023 that will continue until the Principal Amount is repaid. In exchange for the consulting fee, the Company will provide management consulting and strategic growth services to CNTNR. The balance of the consulting fee is recorded as an accounts receivable. As of December 31, 2023, the accounts receivable has a zero balance. The Amended CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the Amended CNTNR Note, CNTNR will pay to the Company all outstanding Principal Amount and interest, plus any outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares). The note was informally extened by the parties to January 31, 2024. Moreover, the Amended CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger with CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued as of December 31, 2023 and will be recorded at fair value as financing income upon issuance at settlement. The interest is calculated on the total balance of the available loan of $1,000,000 starting on the date of the first transfer on February 28, 2023. As of December 31, 2023, the CNTNR Note and the Amended CNTNR Note have accrued interest of $116,893 with an outstanding principal of $1,548,000. The increase in the principal amount from $1,000,000 to $1,548,000 is due to the Company extending an additional loan of $548,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note. The parties are currently working on amending the Amended CNTNR Note to reflect the increase on the principal amount of such note.

Consulting Agreement Related Pa

Consulting Agreement Related Party	6 Months Ended
Consulting Agreement Related Party	Dec. 31, 2023
Consulting Agreement Related Party
Consulting Agreement - Related Party	Note 10 – Consulting Agreement Related Party On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services, including the supervision of the Company’s senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review. The contract period is 12 months with no option for renewal thereafter. The Company has paid Steve Hall a one-time flat service fee of $250,000 on January 31, 2023. Compensation is without recourse and there is no requirement for performance of services during the term of the contract. The contract has expired on December 31, 2023. On December 1, 2023, Hawkeye entered into a consulting agreement with Christ Mulgrew, the Chief Financial Officer of the Company, to provide consulting services with monthly compensation of $3,500. The contract period is 12 months unless earlier termination. Any extension of the term will be suject to mutual written agreement. On December 1, 2023, Hawkeye entered into a consulting agreement with Corby Marshall, the Chief Executive Officer of the Company, to provide consulting services with monthly compendsation of $500. The contract period is 12 months unless earlier termination. Any extension of the term will be suject to mutual written agreement.

Stockholders Equity

Stockholders Equity	6 Months Ended
Stockholders Equity	Dec. 31, 2023
Stockholders Equity
Stockholders' Equity	Note 11 - Stockholders’ Equity Stock Purchase Warrants Transactions in stock purchase warrants for the three months ended December 31, 2023 are as follows: Number of Warrants Weighted Average Exercise Price Balance at June 30, 2023 239,401 $ 1.04 Expired - - Balance at September 30, 2023 239,401 1.04 Expired - - Balance at December 31, 2023 239,401 $ 1.04 The composition of the Company’s warrants outstanding at December 31, 2023 are as follows: Exercise Price Number of Warrants Weighted Average Remaining Life (in years) $ 0.30 35,000 0.33 $ 0.50 66,667 0.33 $ 1.00 70,867 0.33 $ 2.00 66,867 0.33 239,401 0.33 The intrinsic value of the warrants as of December 31, 2023 was $0. Stock Options Transactions in stock options for the six months ended December 31, 2023 are as follows: Weighted average Number of Weighted average remaining life options exercise price (in years) Outstanding, June 30, 2023 425,600 1.41 3.41 Granted - - - Cancelled - - - Exercised - - - Outstanding, September 30, 2023 425,600 1.41 3.16 Granted - - - Cancelled - - - Exercised - - - Exercisable, December 31, 2023 425,600 $ 1.41 2.90 During the three months ended December 31, 2023, the Company had not granted any stock options. And all stock options were vested at the fiscal year end June 30, 2023. At December 31, 2023, the intrinsic value of the outstanding options was $0.

Stock Reverse Split

Stock Reverse Split	6 Months Ended
Stock Reverse Split	Dec. 31, 2023
Stock Reverse Split
Stock Reverse Split	Note 12 – Stock Reverse Split Hawkeye filed a form of 8K/A on March 22, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remain the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company had 4,227,222 shares of common stock issued and outstanding on February 8, 2023. In addition, at the effective time of the Reverse Split, all common shares, warrants, options and the related financial information as filed in the Quarterly Report on Form 10-Q of 3 rd

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Dec. 31, 2023
Commitments and Contingencies
Commitments and Contingencies	Note 13 – Commitments and Contingencies On July 17, 2020, the Company entered into a Membership Agreement with Eagle and Ikon to form HIE. Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. HIE did not have operating activities during the quarter ended December 31, 2023. Detailed discussions are included in Note 3 – Loan payable due to Eagle - JV partner. On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services. Transactions are described in detail in Note 10 - Consulting Agreement - Related Party. On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”) of which the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. Detailed discussions are included in Note 9 - Note Receivable.

Subsequent Events

Subsequent Events	6 Months Ended
Subsequent Events	Dec. 31, 2023
Subsequent Events
Subsequent Events	Note 14 - Subsequent Events Management has evaluated subsequent events through the date of these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2023
Summary of Significant Accounting Policies
Business Overview	Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources. Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).
Basis of presentation	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.
Use of estimates	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.
Fair value measurements	When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.
Revenue recognition	As of December 31, 2023, and 2022, the Company had no revenue.
Cost of sales	As of December 31, 2023, and 2022, the Company had no cost of sales.
Basic and diluted earnings per share	Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended December 31, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows: December 31, December 31, 2023 2022 Warrants 239,401 239,401 Options 425,600 425,600 Convertible notes 6,972,559 5,679,287 Total possible dilutive shares 7,637,560 6,344,288
Recent Accounting Pronouncements	Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 31, 2023
Summary of Significant Accounting Policies
Schedule Of potentially dilutive common stock	December 31, December 31, 2023 2022 Warrants 239,401 239,401 Options 425,600 425,600 Convertible notes 6,972,559 5,679,287 Total possible dilutive shares 7,637,560 6,344,288

Stockholders Equity (Tables)

Stockholders Equity (Tables)	6 Months Ended
Stockholders Equity (Tables)	Dec. 31, 2023
Stockholders Equity
Schedule of transactions in stock purchase warrants	Number of Warrants Weighted Average Exercise Price Balance at June 30, 2023 239,401 $ 1.04 Expired - - Balance at September 30, 2023 239,401 1.04 Expired - - Balance at December 31, 2023 239,401 $ 1.04
Schedule of warrants outstanding	Exercise Price Number of Warrants Weighted Average Remaining Life (in years) $ 0.30 35,000 0.33 $ 0.50 66,667 0.33 $ 1.00 70,867 0.33 $ 2.00 66,867 0.33 239,401 0.33
Schedule Of Transactions in stock options	Weighted average Number of Weighted average remaining life options exercise price (in years) Outstanding, June 30, 2023 425,600 1.41 3.41 Granted - - - Cancelled - - - Exercised - - - Outstanding, September 30, 2023 425,600 1.41 3.16 Granted - - - Cancelled - - - Exercised - - - Exercisable, December 31, 2023 425,600 $ 1.41 2.90

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - shares	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Convertible Note [Member]
Total possible dilutive shares	6,972,559	5,679,287
Options [Member]
Total possible dilutive shares	425,600	425,600
Total Possible Dilutive Shares [Member]
Total possible dilutive shares	7,637,560	6,344,288
Warrant [Member]
Total possible dilutive shares	239,401	239,401

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended				6 Months Ended
Going Concern (Details Narrative) - USD ($)	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Going Concern
Net loss	$ (173,254)	$ (214,247)	$ (266,292)	$ (215,096)	$ (387,501)	$ (481,388)
Accumulated deficit	$ (12,495,987)				$ (12,495,987)		$ (12,108,487)

Loan payable due to Eagle JV _2

Loan payable due to Eagle JV partner (Details Narrative) - USD ($)	1 Months Ended
	Jul. 17, 2020	Dec. 31, 2023
Description of membership agreement	the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle
Loan Payable		$ 442,251
Profit sharing for each member, percentage	33.30%
HIE [Member]
Investment in HIE		$ 0
Percentage of contingent liablility to repay origination loan and additional contribution	33.30%

Inventory Financing Payable r_2

Inventory Financing Payable related party (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Oct. 01, 2021	Feb. 19, 2021	Jun. 30, 2021	Dec. 31, 2023	Feb. 27, 2023	Dec. 31, 2022
Inventory Financing Payable related party
Advances from related party		$ 1,000,000
Related party transaction description		The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle
Repayment to related party			$ 500,000
Description Of Business	February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter
Common stock shares conversion price	$ 0.02
Accrued interest				$ 215,342		$ 115,342
Principal amount				$ 500,000	$ 1,000,000

Line of Credit related party (D

Line of Credit related party (Details Narrative) - USD ($)	Oct. 01, 2021	Dec. 31, 2023	Dec. 31, 2022
Outstanding line of credit		$ 525,000	$ 465,000
Accrued interest payable		$ 154,170	$ 51,849
On October 1, 2021 \| Line of credit related party description \| Steve Hall [Member]
Line of credit related party description	agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter
Expiry date of line of credit	October 1, 2023

Promissory notes payable rela_2

Promissory notes payable related party (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Mar. 29, 2023	Dec. 31, 2023	Jun. 30, 2023
Promissory notes payable related party
Promissory note payable - related party	$ 1,000,000	$ 1,729,750	$ 1,000,000
Annual interest rate of loan	12%
Note repayment terms, description		the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants
Accrued interest related party		$ 122,291

Accrued expenses related party

Accrued expenses related party (Details Narrative)	13 Months Ended
Accrued expenses related party (Details Narrative)	Sep. 30, 2022 USD ($)
Hawkeye Systems, Inc [Member]
Accepted deposits	$ 33,218

Note receivable (Details Narrat

Note receivable (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended
Note receivable (Details Narrative) - USD ($)	Feb. 28, 2023	Feb. 27, 2023	Dec. 31, 2023	Dec. 31, 2022
Advanced payment		$ 200,000
Commitment fees rate		5%
Principal amount		$ 1,000,000	$ 500,000
Accrued interest			154,170	$ 51,849
CNTNR [Member]
Advanced payment		$ 200,000
Commitment fees rate		5%
Monthly consulting fee			5,000
Annual interest rate		12%
Maturity date		Sep. 30, 2023
Principal amount			6,170,879
Discripiton of warrants discount		The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023
Accrued interest			$ 116,893
Interest amount	$ 1,000,000
Description of Extending Additional Loan			The increase in the principal amount from $1,000,000 to $1,548,000 is due to the Company extending an additional loan of $548,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note

Consulting Agreement - Related

Consulting Agreement - Related Party (Details Narrative) - USD ($)		1 Months Ended
	Dec. 01, 2023	Jan. 31, 2023
Consulting Agreement [Member]
Service fee		$ 250,000
Contract period	12 months
Consulting Agreement With Christ [Member]
Compensation amount	$ 3,500
Contract period	12 months
Consulting Agreement With Corby Marshall [Member]
Compensation amount	$ 500
Contract period	12 months

Stockholders Equity (Details)

Stockholders Equity (Details) - Stock Purchase Warrants [Member] - USD ($)	3 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Warrant shares, Beginning	239,401	239,401
Warrant shares, Expired	$ 0	$ 0
Warrant shares, Ending	239,401	239,401
Weighted average exercise price, Beginning	$ 1.04	$ 1.04
Weighted average exercise price, Expired	0	0
Weighted average exercise price, Ending	$ 1.04	$ 1.04

Stockholders Equity (Details 1)

Stockholders Equity (Details 1)	6 Months Ended
Stockholders Equity (Details 1)	Dec. 31, 2023 $ / shares shares
Warrants outsanding 1 [Member]
Exercise Price \| $ / shares	$ 0.30
Number of Warrants	35,000
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding 2 [Member]
Exercise Price \| $ / shares	$ 0.50
Number of Warrants	66,667
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding 3 [Member]
Exercise Price \| $ / shares	$ 1
Number of Warrants	70,867
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding 4 [Member]
Exercise Price \| $ / shares	$ 2
Number of Warrants	66,867
Weighted Average Remaining Life (in years)	10 days
Warrants outsanding [Member]
Number of Warrants	239,401
Weighted Average Remaining Life (in years)	10 days

Stockholders Equity (Details 2)

Stockholders Equity (Details 2) - Stock Options [Member] - $ / shares	3 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Number of options, beginning balance	425,600	425,600
Number of options, ending balance	425,600	425,600
Number of options, Exercisable	425,600
Weighted Average Exercise Price, beginning balance	$ 1.41	$ 1.41
Weighted Average Exercise Price, ending balance	1.41	$ 1.41
Weighted Average Exercise Price, Exercisable	$ 1.41
Weighted average remaining life, beginning	3 months 4 days	3 months 12 days
Weighted average remaining life, ending	2 years 10 months 24 days	3 years 1 month 28 days
Weighted average remaining life, exercisable	2 months 27 days

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative)	Dec. 31, 2023 USD ($)
Warrant [Member]
Intrinsic value of the outstanding options	$ 0
Stock Options [Member]
Intrinsic value of the outstanding options	$ 0

Stock Reverse Split (Details Na

Stock Reverse Split (Details Narrative) - $ / shares	6 Months Ended
Stock Reverse Split (Details Narrative) - $ / shares	Dec. 31, 2023	Jun. 30, 2023
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares outstanding	5,552,222	5,552,222
Stock Reverse Split [Member]
Common stock par value	$ 0.0001
Common stock, shares outstanding	4,227,222
Description of stock reverse split	The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
Commitments and Contingencies (Details Narrative) - USD ($)	Feb. 27, 2023	Dec. 31, 2023
Commitments and Contingencies
Origination Loan		33.30%
Principal amount	$ 1,000,000	$ 500,000
Advanced payment	$ 200,000
Commitment fees rate	5%